Hyundai MOBIS moves forward with its new 'Move Improved' campaign

Hyundai MOBIS moves forward with its new 'Move Improved' campaign

With a tagline 'Move Improved', advanced mobility technologies are introduced in a joyful and relatable story of driving experience. Through social media launch, it aims to create a better understanding of the Hyundai MOBIS' brand and its mobility...

Hyundai Mobis to Showcase World's First Full-Windshield Holographic Display at CES 2025

Hyundai Mobis to Showcase World's First Full-Windshield Holographic Display at CES 2025

The groundbreaking display projects critical driving information across the entire width of the windshield, offering a panoramic and immersive experience that spans from the driver's seat to the passenger's seat. Hyundai Mobis will also present its...

GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)

GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)

YOGIN, South Korea, Dec. 18, 2023 /PRNewswire/ -- GC Biopharma Corp (006280.KS) today announces that the US Food and Drug Administration (FDA) has approved ALYGLO (immune globulin intravenous, human-stwk) 10% Liquid, formerly referred to as...

menu
menu